Alembic Pharmaceuticals LimitedNSE: APLLTD

Press Release Jun 17 2024

· Issued by Alembic Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-jun-17-2024-2

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 17, 2024, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Icatibant Injection, 30 mg/3 mL (10 mg/mL) Single-Dose Prefilled Syringe.".

View Attachment

6ix hasn’t read this filing yet.

Alembic Pharmaceuticals Limited on 6ix

Earlier from Alembic Pharmaceuticals

Later from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases